603882 金域醫學
按盤價 
33.470 +0.010 (+0.030%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.159 | 7.571 | 36.885 | 43.992 | 49.810 |
| 總資產報酬率 ROA (%) | 0.825 | 5.015 | 22.357 | 25.527 | 27.363 |
| 投入資產回報率 ROIC (%) | 1.059 | 6.975 | 33.452 | 38.736 | 31.906 | 邊際利潤分析 |
| 銷售毛利率 (%) | 35.154 | 36.478 | 43.128 | 47.292 | 46.685 |
| 營業利潤率 (%) | 1.961 | 8.897 | 21.628 | 23.250 | 22.039 |
| 息稅前利潤/營業總收入 (%) | 1.690 | 8.657 | 21.376 | 23.090 | 22.175 |
| 淨利潤/營業總收入 (%) | 1.493 | 7.458 | 18.383 | 19.790 | 19.086 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 522.470 | 122.168 | 106.417 | 101.367 | 100.216 |
| 價值變動淨收益/利潤總額(%) | -5.339 | 35.522 | -0.325 | -0.266 | -1.031 |
| 營業外收支淨額/利潤總額(%) | -14.874 | -2.631 | -0.798 | -1.063 | -0.353 | 償債能力分析 |
| 流動比率 (X) | 3.276 | 3.073 | 2.327 | 2.127 | 2.060 |
| 速動比率 (X) | 3.181 | 2.981 | 2.239 | 2.035 | 1.957 |
| 資產負債率 (%) | 27.009 | 27.365 | 36.104 | 39.330 | 41.612 |
| 帶息債務/全部投入資本 (%) | 7.117 | 4.966 | 4.747 | 7.664 | -- |
| 股東權益/帶息債務 (%) | 1,271.691 | 1,855.251 | 1,940.682 | 1,158.661 | 754.907 |
| 股東權益/負債合計 (%) | 264.120 | 259.693 | 172.122 | 149.086 | 137.082 |
| 利息保障倍數 (X) | -98.005 | -701.395 | -263.228 | 273.356 | 104.148 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 251.098 | 260.537 | 135.972 | 110.923 | 0.000 |
| 存貨周轉天數 (天) | 17.338 | 21.684 | 15.346 | 16.678 | 0.000 |
| 備註： | 即時報價更新時間為 03/12/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
